Christensen, Michael C.; Moskowitz, Alan; Talati, Ardesheer - In: Economics of Innovation and New Technology 16 (2007) 5, pp. 357-370
The placebo-controlled, double-blind, randomized clinical trial (RCT) holds unique advantages for evaluating medical technologies, and figures prominently in clinical drug investigations. However, medicine, like other social sectors, has experienced a movement toward evidence-based practice and...